Clinical Trials Browser

Interventional × Uterine Cervical Neoplasms × Radiotherapy × Clear all

NCT02466971 2026-04-13

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Phase 3 Active not recruiting

450 enrolled 11 charts

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT03614949 2026-04-01

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Phase 2 Active not recruiting

Uterine Cervical Neoplasms

NCT00421096 2026-03-13

GEMCOL

Phase 2 Terminated

Uterine Cervical Neoplasms

NCT05521997 2026-03-13

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT03968406 2026-03-11

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Phase 1 Recruiting

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT03256916 2026-02-24

NELCER

Phase 3 Completed

Uterine Cervical Neoplasms

NCT07340489 2026-01-14

Serplulimab for Locally Advanced Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT06727617 2026-01-06

Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT06416696 2026-01-02

Toripalimab for High-risk Locally Advanced Cervical Cancer

Phase 2 Active not recruiting

Uterine Cervical Neoplasms

NCT04567771 2025-11-14

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Phase NA Recruiting

Pelvic Inflammatory Disease, Uterine Cervical Neoplasms, Endometriosis, Endometrial Neoplasms

NCT03738228 2025-11-12

Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer

Phase 1 Completed

40 enrolled 17 charts

Uterine Cervical Neoplasms

NCT03298893 2025-09-19

NiCOL

Phase 1/2 Completed

Uterine Cervical Neoplasms

NCT03277482 2025-05-31

Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer

Phase 1 Terminated

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT03255252 2025-05-18

IMMUVIX

Phase 2 Terminated

Uterine Cervical Neoplasms

NCT06942416 2025-04-24

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Neoplasms

NCT05857631 2025-04-15

PARCERII

Phase NA Recruiting

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06353061 2025-01-14

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

Phase 2 Recruiting

Hypoxia, Uterine Cervical Neoplasms

NCT01566240 2024-12-05

INTERLACE

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

NCT05051696 2024-06-04

Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies

Phase 2 Active not recruiting

Uterine Cervical Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06426056 2024-05-23

Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT01088347 2024-04-19

Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer

Phase 1/2 Completed

Uterine Cervical Neoplasms

NCT04551950 2024-03-08

Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)

Phase 1 Completed

25 enrolled 14 charts

Uterine Cervical Neoplasms, Camurati-Engelmann Syndrome

NCT06128460 2023-11-30

Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT05588219 2023-11-24

Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT03534713 2023-09-21

ONCOCOL01

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT06039891 2023-09-15

Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT05511623 2023-09-11

Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT05277688 2022-09-16

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Phase 2 Withdrawn

Uterine Cervical Neoplasms, HIV Infections

NCT05310383 2022-04-11

Tislelizumab and Radiotherapy for Recurrent Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT04664244 2020-12-22

Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT03146039 2020-02-05

NICER

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT01991808 2019-11-26

Suitability of DCE-MRI for Detection of Vascular Changes After VBT

Phase NA Completed

16 enrolled 7 charts

Carcinoma, Uterine Cervical Neoplasms

NCT04121975 2019-10-10

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT00806117 2019-07-30

STARS

Phase 3 Unknown

Uterine Cervical Neoplasms

NCT03559803 2019-01-22

A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer

Phase NA Unknown

Uterine Cervical Neoplasms

NCT03220009 2018-10-03

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Phase 2 Withdrawn

DermatologicGastrointestinalGynecologic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Vaginal Neoplasms, Vulvar Neoplasms

NCT00287911 2017-12-02

Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer

Phase 1 Completed

Uterine Cervical Neoplasms

NCT00428194 2017-11-29

Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer

Phase 1 Withdrawn

Uterine Cervical Neoplasms

NCT03332069 2017-11-07

mEHT

Phase 3 Unknown

Hyperthermia, Uterine Cervical Neoplasms

NCT00600210 2017-08-23

Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT03249519 2017-08-15

Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer

Phase NA Recruiting

Hyperthermia, Uterine Cervical Neoplasms

NCT03175848 2017-07-21

Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer

Phase NA Unknown

Uterine Cervical Neoplasms

NCT01461772 2017-05-31

Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer

Phase 3 Terminated

Uterine Cervical Neoplasms

NCT00452920 2016-12-15

Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer

Phase 1/2 Withdrawn

Uterine Cervical Neoplasms

NCT00039338 2016-12-05

Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer

Phase 3 Unknown

Uterine Cervical Neoplasms

NCT00003704 2016-07-06

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

Phase 1 Completed

GastrointestinalGenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Fallopian Tube Neoplasms, Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Testicular Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT02501278 2016-05-13

A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT01755845 2016-04-28

Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer Patients

Phase 3 Unknown

Uterine Cervical Neoplasms

NCT01756170 2016-04-28

Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients

Phase 3 Unknown

Uterine Cervical Neoplasms